Remove Advantage Remove Biotech Remove Due Diligence
article thumbnail

The Evolution of AI in Asset Management

Alpha Sense BI

As time goes on and more firms adopt AI tools, these capabilities will become even more essential to maintain a competitive advantage. The AI Advantage It’s clear that AI is here to stay, and the time is now for firms to get on board with this technology.

article thumbnail

Slow Start to Venture Capital Funding in 2024

Alpha Sense BI

Below, we explore the factors constraining venture capital funding into the first half of the year, and the ways investors can leverage crucial market intelligence to gain a competitive advantage in the shifting landscape. The VC Funding Dryspell Venture capital investment fell to the lowest activity in nearly five years for Q1 2024.

Capital 69
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

M&A Trends and Outlook for 2023

Alpha Sense BI

Three years later, despite macroeconomic uncertainties, investors remain attracted to this space, particularly the more innovative and tech-influenced sub-sectors like biotech and MedTech. Many pharma companies with expiring patents are on the hunt to acquire biotech companies to address gaps in drug pipelines.

Biotech 97
article thumbnail

A Comprehensive Guide to Mastering Expert Call Interviews from the Analyst Perspective

Alpha Sense BI

That expert call may be one of the single advantages in the stack. Because your competitors likely have access to the same sources, this doesn’t provide a competitive advantage. In other words, what areas in your research topic can expert calls provide you with a competitive advantage?